Healthcare & Life Sciences
SciNeuro
United Kingdomscineuro.com
SciNeuro is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series B, 1 tracked investor.
activeseries-b
series-b
Stage
2020
Founded
1
Investors
About SciNeuro
SciNeuro is a company founded in 2020 headquartered in the United Kingdom. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
SciNeuro Pharmaceuticals develops innovative therapies for central nervous system (CNS) diseases, focusing on neurodegenerative conditions like Alzheimer's and Parkinson's. The company employs a proprietary blood-brain barrier shuttle platform to deliver therapeutic molecules to the brain.
Explore SciNeuro's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.